INT233303

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.07
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.34
Pain Relevance 0.05

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (SRY) signal transduction (CD4) cell adhesion (CD4)
nucleus (SRY) plasma membrane (CD4) DNA binding (SRY)
CD4 (Homo sapiens)
SRY (Homo sapiens)
Pain Link Frequency Relevance Heat
peripheral neuropathy 1 91.76 High High
Potency 4 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
headache 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Pancreatitis 1 92.44 High High
Peripheral Neuropathy 1 91.76 High High
Adverse Drug Reaction 4 90.48 High High
Acquired Immune Deficiency Syndrome Or Hiv Infection 36 46.24 Quite Low
Lipodystrophy 4 41.00 Quite Low
Toxicity 16 25.84 Quite Low
Hepatitis B Virus Infection 11 20.72 Low Low
Vomiting 4 5.00 Very Low Very Low Very Low
Hepatitis 3 5.00 Very Low Very Low Very Low
Renal Insufficiency 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
In addition, use of TDF with didanosine has also been associated with paradoxical CD4 declines or less than robust CD4 increases in some, but not all studies (Barrios 2005; Karrer et al 2005; Torti et al 2007).
CD4 Binding (associated) of TDF
1) Confidence 0.07 Published 2007 Journal Therapeutics and Clinical Risk Management Section Body Doc Link PMC2387297 Disease Relevance 0.34 Pain Relevance 0.05

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox